A previous study showed that a protein included in BC, the κ-casein-derived bovine glycomacropeptide is able to reduce the DAI, to lower the colonic damage score, and to switch off the inflammation inhibiting the NF-κB-mediated pro-inflammatory cytokine and other inflammatory markers expression [38]. This evidence concerns the gene NFKB1 and breast cancer.